Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 3/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | HTR2B | P41595 | 1/20 | 0.35 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.34 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.33 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.33 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.33 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | CD38 | P28907 | 3/20 | 0.32 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.30 |
| ▸ | CYP21A2 | P08686 | 1/20 | 0.30 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29588780 | 1.00 | IDO1 (0.40) | IDO1HTR2AHTR2CHTR2BCHRNA7 | |
| SCHEMBL24313632 | 0.81 | CYP11B1 (0.43) | CYP11B1 | |
| SCHEMBL12174452 | 0.69 | HDAC4 (0.42) | — | |
| SCHEMBL24313611 | 0.67 | ESR2 (0.36) | — | |
| SCHEMBL24313736 | 0.67 | TBXAS1 (0.39) | HTR2AHTR2CHTR2BCA12CA9 | |
| SCHEMBL29588188 | 0.67 | TBXAS1 (0.39) | HTR2AHTR2CHTR2BCA12CA9 | |
| SCHEMBL31005858 | 0.67 | CD38 (0.41) | HTR2AHTR2CHTR2BCD38 | |
| SCHEMBL25192493 | 0.67 | CD38 (0.41) | HTR2AHTR2CHTR2BCD38 | |
| SCHEMBL24313735 | 0.64 | HTR2A (0.35) | HTR2AHTR2CHTR2B | |
| SCHEMBL24314202 | 0.64 | ESR2 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022081842-A1 | SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER | THE BROAD INSTITUTE, INC. (US) | 2022-04-21 | — | — | WO | disclosed |